Most medication errors are preventable with the right conditions. Successful technology implementation requires careful planning, proper training, and a commitment to system-wide improvements, as explained by Stéphane Boulanger, Policy Advisor at the European Patient Safety Foundation (EUPSF).
A new study by the University of Manchester has found that a new clotbusting drug is significantly better at treating ischemic stroke than existing treatments.
Amidst a stark rise in US syphilis cases, researchers have secured a $2.7 million NIH grant to develop the first comprehensive, rapid test for active infection that aims to deliver accurate results within 10 minutes.
With areas of expertise in cannabis use and brain disorders, Justine Renard from the Canadian Centre on Substance Use and Addiction spoke to Lorna Rothery about the prevalence and potential impacts of cannabis use during pregnancy.
University Hospitals Coventry and Warwickshire (UHCW) NHS Trust is to lead a clinical trial of a novel device aimed at addressing miscarriage symptoms.
A landmark study presented at ESCMID Global 2025 reveals the devastating impact of antimicrobial resistance (AMR) on children's health. In 2022, over 3 million children worldwide died from antibiotic-resistant infections, highlighting the urgent need for global action.
The UK government is investing £82.6 million in groundbreaking research to harness the power of artificial intelligence (AI) to transform cancer care and accelerate drug discovery.
New research in the Canadian Medical Association Journal links emergency department opioid prescriptions to small increases in future opioid use and hospitalisations, but not death or overdose. The study highlights the need for cautious prescribing, especially in high-risk patients.
A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient. Researchers identified a RUFY1-RET fusion, highlighting the need for advanced genetic testing to guide treatment strategies and combat evolving resistance.
Chronic pain can affect a person’s life in a myriad of ways. Asal Shirazi BEM, Founder of the Autoimmune Support & Awareness Foundation (ASA Foundation), talks us through some of the conditions associated with chronic pain and the advancements in pain management.
In a groundbreaking initiative to treat severe mental health conditions, a new research group in Cambridgeshire is conducting clinical trials to investigate the potential benefits of empathogens and psychedelics.
Adeem Azhar, Co-Founder and Chief Executive Officer at Core Prescribing Solutions, explains how the company’s innovative solutions are helping to tackle challenges within primary care and positively support the healthcare workforce.
